James Priano
Pharmacist
601 E Rollins St, Orlando
Florida, 32803-1248
407-609-0420 James Priano is a pharmacist in Orlando, Florida. Patients can reach him at 601 E Rollins St, Orlando or contact him on 407-609-0420. Active license number of James Priano is PS53980 for Pharmacist in Florida.
James Priano is
Complete Profile:
James Priano speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
| Name: | James Priano |
| Specialization: | Pharmacist |
| Credentials: | PHARMD |
| Gender: | Male |
| Location: | 601 E Rollins St, Orlando,
Florida, 32803-1248 |
| Phone: | 407-609-0420 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of James Priano are as mentioned below.
| NPI Number: | 1326958901 |
| NPI Enumeration Date: | 08 Sep, 2026 |
| NPI Last Update On: | 08 Sep, 2026 |
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for James Priano are as mentioned below.
| Specialization | License Number | State | Status | |
| Pharmacist | PS53980 | Florida | Primary | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 601 E Rollins St,
Orlando, Florida |
| Zip: | 32803-1248 |
| Phone Number: | -- |
Patients can reach James Priano at
601 E Rollins St, Orlando, Florida or can
call on phone at 407-609-0420.
Comments/ Reviews:
Read all the reviews posted for James Priano below. You may also share your own experience with James Priano. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 September, 2026.